We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novel Excipient Pilot Can Flag Safety Issues, Says CDER Official
Novel Excipient Pilot Can Flag Safety Issues, Says CDER Official
The FDA’s newly launched novel excipient review pilot program aims to identify possible safety issues before they can delay a drug’s application, said a senior official within the Center for Drug Evaluation and Research (CDER).